Multi-Disciplinary Treatment of Gastric Cancer with Liver Metastases_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 陈凛 , 卢灿荣

Corresponding author：

陈凛, Email: chenlinbj@vip.sina.com

Keywords：

胃肿瘤; 肿瘤转移; 肝脏; 治疗

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 陈凛,卢灿荣. Multi-Disciplinary Treatment of Gastric Cancer with Liver Metastases. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2012, 19(1): 4-7. doi: Copy

1.	Okano K， Maeba T， Ishimura K， et al.Hepatic resection for　metastatic tumors from gastric cancer[J].AnnSurg， 2002， 235(1)： 86-91.
2.	Sakamoto Y， Sano T， Shimada K， et al.Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer[J].J Surg Oncol， 2007， 95(7)： 534-539.
3.	周辉，金哲俊，翟博，等.胃癌肝转移肝切除的预后分析[J].肝胆胰外科杂志， 2006， 18(3)：147-149.
4.	王洪义，李明，顾晋. 胃癌肝转移患者的手术治疗及预后分析[J].中华胃肠外科杂志， 2005， 8(1)： 11-13.
5.	Cheon SH， Rha SY， Jeung HC， et al.Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases[J].Ann Oncol， 2008， 19(6)：1146-1153.
6.	解世亮，邵永孚，冯强.胃癌肝转移的外科治疗[J].中华胃肠外科杂志， 2005， 8(1)：14-16.
7.	Chen L， Liu J.Value of palliative gastrectomy and transarterial chemoembolization for gastric cancer with synchronous liver metastases[C].9th International Gastric Cancer Congress， Korea.2011：123.
8.	Kerkar SP， Kemp CD， Duffy A， et al.The GYMSSA trial：a prospective　randomized trial comparing gastrectomy， metastasectomy plus systemic therapy versus systemic therapy alone[J].Trials， 2009， 23(10)：121-129.
9.	Mayo SC， Pawlik TM.Thermal ablative therapies for secondary hepatic malignancies[J].Cancer J， 2010， 16(2)：111-117.
10.	Kim HR， Ha Cheon S， Lee KH， et al.Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma[J].Int J Hyperthermia， 2010， 26(4)：305-315.
11.	Boutros C， Somasundar P， Garrean S， et al.Microwave coagulation therapy for hepatic tumors： review of the literature and critical analysis[J].Surg Oncol， 2010， 19(1)：e22-e32.
12.	梁萍，董宝玮，于晓玲，等.超声引导经皮微波消融治疗肝转移癌疗效评价[J].中华医学杂志， 2006， 86(12)：806-810.
13.	Ojima H， Ootake S， Yokobori T， et al.Treatment of multipleliver metastasis from gastric carcinoma[J].World J Surg Oncol， 2007， 5：70-73.
14.	Yamakado K， Nakatsuka A， Takaki H， et al.Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer[J].J Vasc Interv Radiol， 2005， 16(12)：1747-1751.
15.	Hirasawa T， Asahara S， Fujisaki S， et al.Transcatheter arterial chemoembolization (TACE) using degradable starch microspheres (DSM) for metastatic liver tumors in patients with gastric cancer[J].Nippon Shokakibyo Gakkai Zasshi， 2008， 105(3)：367-372.
16.	Koizumi W， Narahara H， Hara T， et al.S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial)：a phaseⅢ trial[J].Lancet Oncol， 2008， 9(3)：215-221.
17.	Ajani JA， Rodriguez W， Bodoky G， et al.Multicenter phase Ⅲ comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study： the FLAGS trial[J].J Clin Oncol， 2010， 28(9)：1547-1553.
18.	Yoshida K， Ninomiya M， Takakura N， et al.Phase Ⅱ study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer[J].Clin Cancer Res， 2006， 12(11Pt1)：3402-3407.
19.	Fujii M.Chemotherapy for advanced gastric cancer： ongoing phaseⅢ study of S-1 alone versus S-1 and docetaxel combination (JACCRO GC03 study)[J].Int J Clin Oncol， 2008， 13(3)：201-205.
20.	LiZY， TangL， ZhangLH， et al.Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer patients with synchronous multiple hepatic metastases：a pilot study[J].Med Oncol， 2010， 27(4)：1314-1318.
21.	Sato Y， Takayama T， Sagawa T， et al.Phase Ⅱ study of S-1， docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer[J].Cancer Chemother Pharmacol， 2010， 66(4)：721-728.
22.	Pinto C， Di Fabio F， Siena S， et al.PhaseⅡ study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal　junction adenocarcinoma (FOLCETUX study)[J].Ann Oncol， 2007， 18(3)：510-517.
23.	Bang YJ， Van Cutsem E， Feyereislova A， et al.Trastuzumab incombination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro oesophageal junction cancer (ToGA)：a phase 3， open-label， randomised controlled trial[J].Lancet， 2010， 376(9742)：687-697.
24.	Kang Y， Ohtsu A， Van Cutsem E， et al.AVAGAST：A randomized，double-blind，placebo-controlled，phaseⅢ study of first-line capecitabine and cisplatin plus bevacizumab or placebo in patients with advanced gastric cancer (AGC)[C].Proc ASCO，Annual Meeting 2010：LBA4007.
25.	NCCN Practice Guidelines in Oncology (Gastric Cancer)-v. 2. 2010 www. nccn. org.
26.	Glimelius B， Ekstrom K， Hoffman K， et al.Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer[J].Ann Oncol， 1997， 8(2)：163-168.

1. Okano K， Maeba T， Ishimura K， et al.Hepatic resection for　metastatic tumors from gastric cancer[J].AnnSurg， 2002， 235(1)： 86-91.
2. Sakamoto Y， Sano T， Shimada K， et al.Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer[J].J Surg Oncol， 2007， 95(7)： 534-539.
3. 周辉，金哲俊，翟博，等.胃癌肝转移肝切除的预后分析[J].肝胆胰外科杂志， 2006， 18(3)：147-149.
4. 王洪义，李明，顾晋. 胃癌肝转移患者的手术治疗及预后分析[J].中华胃肠外科杂志， 2005， 8(1)： 11-13.
5. Cheon SH， Rha SY， Jeung HC， et al.Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases[J].Ann Oncol， 2008， 19(6)：1146-1153.
6. 解世亮，邵永孚，冯强.胃癌肝转移的外科治疗[J].中华胃肠外科杂志， 2005， 8(1)：14-16.
7. Chen L， Liu J.Value of palliative gastrectomy and transarterial chemoembolization for gastric cancer with synchronous liver metastases[C].9th International Gastric Cancer Congress， Korea.2011：123.
8. Kerkar SP， Kemp CD， Duffy A， et al.The GYMSSA trial：a prospective　randomized trial comparing gastrectomy， metastasectomy plus systemic therapy versus systemic therapy alone[J].Trials， 2009， 23(10)：121-129.
9. Mayo SC， Pawlik TM.Thermal ablative therapies for secondary hepatic malignancies[J].Cancer J， 2010， 16(2)：111-117.
10. Kim HR， Ha Cheon S， Lee KH， et al.Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma[J].Int J Hyperthermia， 2010， 26(4)：305-315.
11. Boutros C， Somasundar P， Garrean S， et al.Microwave coagulation therapy for hepatic tumors： review of the literature and critical analysis[J].Surg Oncol， 2010， 19(1)：e22-e32.
12. 梁萍，董宝玮，于晓玲，等.超声引导经皮微波消融治疗肝转移癌疗效评价[J].中华医学杂志， 2006， 86(12)：806-810.
13. Ojima H， Ootake S， Yokobori T， et al.Treatment of multipleliver metastasis from gastric carcinoma[J].World J Surg Oncol， 2007， 5：70-73.
14. Yamakado K， Nakatsuka A， Takaki H， et al.Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer[J].J Vasc Interv Radiol， 2005， 16(12)：1747-1751.
15. Hirasawa T， Asahara S， Fujisaki S， et al.Transcatheter arterial chemoembolization (TACE) using degradable starch microspheres (DSM) for metastatic liver tumors in patients with gastric cancer[J].Nippon Shokakibyo Gakkai Zasshi， 2008， 105(3)：367-372.
16. Koizumi W， Narahara H， Hara T， et al.S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial)：a phaseⅢ trial[J].Lancet Oncol， 2008， 9(3)：215-221.
17. Ajani JA， Rodriguez W， Bodoky G， et al.Multicenter phase Ⅲ comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study： the FLAGS trial[J].J Clin Oncol， 2010， 28(9)：1547-1553.
18. Yoshida K， Ninomiya M， Takakura N， et al.Phase Ⅱ study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer[J].Clin Cancer Res， 2006， 12(11Pt1)：3402-3407.
19. Fujii M.Chemotherapy for advanced gastric cancer： ongoing phaseⅢ study of S-1 alone versus S-1 and docetaxel combination (JACCRO GC03 study)[J].Int J Clin Oncol， 2008， 13(3)：201-205.
20. LiZY， TangL， ZhangLH， et al.Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer patients with synchronous multiple hepatic metastases：a pilot study[J].Med Oncol， 2010， 27(4)：1314-1318.
21. Sato Y， Takayama T， Sagawa T， et al.Phase Ⅱ study of S-1， docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer[J].Cancer Chemother Pharmacol， 2010， 66(4)：721-728.
22. Pinto C， Di Fabio F， Siena S， et al.PhaseⅡ study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal　junction adenocarcinoma (FOLCETUX study)[J].Ann Oncol， 2007， 18(3)：510-517.
23. Bang YJ， Van Cutsem E， Feyereislova A， et al.Trastuzumab incombination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro oesophageal junction cancer (ToGA)：a phase 3， open-label， randomised controlled trial[J].Lancet， 2010， 376(9742)：687-697.
24. Kang Y， Ohtsu A， Van Cutsem E， et al.AVAGAST：A randomized，double-blind，placebo-controlled，phaseⅢ study of first-line capecitabine and cisplatin plus bevacizumab or placebo in patients with advanced gastric cancer (AGC)[C].Proc ASCO，Annual Meeting 2010：LBA4007.
25. NCCN Practice Guidelines in Oncology (Gastric Cancer)-v. 2. 2010 www. nccn. org.
26. Glimelius B， Ekstrom K， Hoffman K， et al.Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer[J].Ann Oncol， 1997， 8(2)：163-168.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Multi-Disciplinary Treatment of Gastric Cancer with Liver Metastases

Abstract Full text Figures/Tables Video References Cited by

Format

Content